Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hereditary Ovarian Carcinoma”

208 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 208 results

Testing effectiveness (Phase 2)Study completedNCT01277744
What this trial is testing

Pilot Study of Hyperthermic Peritoneal Perfusion (HIPEC) for Adolescent and Young Adults With Desmoplastic Small Round Cell Tumor

Who this might be right for
Advanced CancersSarcoma
M.D. Anderson Cancer Center 22
Testing effectiveness (Phase 2)Study completedNCT00003173
What this trial is testing

High-Dose Thiotepa Plus Peripheral Stem Cell Transplantation in Treating Patients With Refractory Solid Tumors

Who this might be right for
Brain and Central Nervous System TumorsChildhood Germ Cell TumorExtragonadal Germ Cell Tumor+5 more
Memorial Sloan Kettering Cancer Center 36
Testing effectiveness (Phase 2)Ended earlyNCT02012192
What this trial is testing

GANNET53: Ganetespib in Metastatic, p53-mutant, Platinum-resistant Ovarian Cancer

Who this might be right for
Epithelial Ovarian CancerFallopian Tube CancerPrimary Peritoneal Cancer
Medical University Innsbruck 133
Not applicableLooking for participantsNCT07498829
What this trial is testing

Population Based Germline Testing for Early Detection and Prevention of Cancer

Who this might be right for
Breast Cancer RiskOvarian Cancer RiskCancer Gene Mutation
Queen Mary University of London 6,000
Not applicableUnknownNCT03979612
What this trial is testing

Evaluation of the Adhesion to the GENEPY Network

Who this might be right for
Hereditary Cancer SyndromeHereditary Breast and Ovarian CancerHereditary Colorectal Endometrial Cancer Syndrome
Institut Claudius Regaud 450
Not applicableLooking for participantsNCT06203106
What this trial is testing

NYSCF Scientific Discovery Biobank

Who this might be right for
ALSAmyotrophic Lateral SclerosisAlzheimer Disease+26 more
New York Stem Cell Foundation Research Institute 10,000
Not applicableEnrolling By InvitationNCT07381985
What this trial is testing

Strategy for Management of Patients With Hereditary Cancer Syndromes (HCS) in a Rural Environment

Who this might be right for
Hereditary Cancer SyndromesBRCA1 Hereditary Breast and Ovarian Cancer SyndromeLynch Syndrome
University of Vermont Medical Center 200
Not applicableStudy completedNCT03119285
What this trial is testing

Genes Contributing to Hereditary Ovarian Cancer in Women and BRCA1/2 Wildtype Families

Who this might be right for
Ovarian Cancer
University of Washington 34
Not applicableLooking for participantsNCT07532434
What this trial is testing

A Bidirectional Cohort Study on Prophylactic Resection Surgery in Populations at Moderate-to-High Risk for Hereditary Ovarian Cancer

Who this might be right for
Ovarian CancerBreast Cancer
Peking University Third Hospital 480
Testing effectiveness (Phase 2)Study completedNCT01333748
What this trial is testing

Search Allelic Imbalance of Expression of BRCA Genes in Hereditary Risk of Breast and/or Ovarian Cancer

Who this might be right for
Hereditary Breast and Ovarian Cancer Syndrome
Centre Francois Baclesse 530
Early research (Phase 1)Study completedNCT05360680
What this trial is testing

In Patients With HLA-A*0201+ and WT1+ Recurrent/Metastatic Cancers

Who this might be right for
Colorectal CancerGastric CancerPancreatic Cancer+1 more
Cue Biopharma 42
Large-scale testing (Phase 3)UnknownNCT03162276
What this trial is testing

Trial of Inquiry Based Stress Reduction (IBSR) Program for BRCA1/2 Mutation Carriers

Who this might be right for
Hereditary Breast and Ovarian Cancer Syndrome
Sheba Medical Center 118
Testing effectiveness (Phase 2)Study completedNCT00321633
What this trial is testing

Carboplatin or Docetaxel in Treating Women With Metastatic Genetic Breast Cancer

Who this might be right for
brca1 Mutation Carrierbrca2 Mutation CarrierBreast Cancer+1 more
University College London Hospitals 148
Not applicableUnknownNCT03294343
What this trial is testing

Risk-Reducing Surgeries for Hereditary Ovarian Cancer

Who this might be right for
Hereditary Breast and Ovarian Cancer SyndromeColorectal Neoplasms, Hereditary NonpolyposisOvariectomy+1 more
Lei Li 600
Not applicableEnded earlyNCT00904514
What this trial is testing

Study of Previously Collected and Stored Tissue Samples From Patients Previously Enrolled in a Completed National Cancer Institute Clinical Trial

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 241
Testing effectiveness (Phase 2)Study completedNCT00109993
What this trial is testing

Campath-1H + FK506 and Methylprednisolone for GVHD

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more
Case Comprehensive Cancer Center 34
Testing effectiveness (Phase 2)Study completedNCT02797977
What this trial is testing

A Phase 1/2 Trial SRA737 in Combination With Gemcitabine and Cisplatin or Gemcitabine Alone in Advanced Cancer Subjects

Who this might be right for
Advanced Solid Tumors
Sierra Oncology LLC - a GSK company 153
Not applicableEnded earlyNCT04508764
What this trial is testing

Implementation of the Families Accelerating Cascade Testing Toolkit (FACTT) for Hereditary Breast and Ovarian Cancer and Lynch Syndrome

Who this might be right for
Hereditary Breast and Ovarian CancerLynch Syndrome
Washington University School of Medicine 96
Not applicableEnded earlyNCT02705924
What this trial is testing

Impact of a Psychoeducational Intervention on Expectations and Coping in Young Women Exposed to a High HBOC Risk

Who this might be right for
Hereditary Breast and Ovarian Cancer Syndrome
Centre Jean Perrin 32
Not applicableStudy completedNCT00248547
What this trial is testing

Aprepitant in Preventing Nausea and Vomiting in Patients Who Are Undergoing a Stem Cell Transplant

Who this might be right for
Cancer
OHSU Knight Cancer Institute 40
Next Page